Clinical features of multiple sclerosis in Western Cuba. A comparison with two other regions in the country;Características clínicas de la esclerosis múltiple en el Occidente de Cuba. Comparación con otras dos regiones del país

Revista de Neurologia

Volumn 38, Issue 9, 2004, Pages 818-823

  Hernández Valero, Erélido ^a,b   Cabrera Gomez J A ^a   Valenzuela, C ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^b Hosp Univ Dr G Aldereguia Lima   (Cuba)

Author keywords

Clinical features; Comparative study; Epidemiology; Multiple sclerosis; Physical examination; Symptoms

Indexed keywords

ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUBA; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; MALE; MENTAL DISEASE; MENTAL STRESS; MULTIPLE SCLEROSIS; PYRAMIDAL SIGN; PYRAMIDAL TRACT; SCHIZOPHRENIA; SENSORY DYSFUNCTION; SKIN COLOR; SYMPTOMATOLOGY;

EID: 3142740382     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3809.2003331     Document Type: Article

References (52)

1. Trapp B, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
2. Luchinetti C, Rodríguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Clin Proc 1997; 72: 665-78.
3. Compston A. Mechanisms underlying the course of multiple sclerosis: which treatment and when? Rev Neurol (Paris) 2000; 156: 3-19.
4. Estrada R. Casos presentados y discutidos en las sesiones de Neuropatología. Revista Cubana de Cirugía 1965; 4: 201-24.
5. Cabrera-Gómez JA, Manero R. Algunas consideraciones sobre esclerosis múltiple en Latinoamérica. Primera estadística presentada en Cuba. Estudio comparativo. Rev Cubana Med 1975; 14: 487-504.
6. Cabrera-Gómez JA, López O. Morbilidad por enfermedades neurológicas en el Servicio de Neurología. Estudio de un quinquenio. Rev Cubana Med 1990; 29: 161-72.
7. Cabrera-Gómez JA, Santana E, Vals O, Casanova M, Alfaro I, González-Quevedo A, et al. Caracterización clínica de pacientes con esclerosis múltiple definida en Cuba. Rev Neurol 1998; 26: 723-8.
8. Díaz de la Fe A. Esclerosis múltiple: caracterizació n clínica de 50 pacientes con esclerosis múltiple clínica definida [trabajo para optar por el título de especialista de primer grado en Neurología]. Santiago de Cuba: Hospital Saturnino Lora; 1997.
9. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers G, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227.
10. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of MS. Ann Neurol 2001; 50: 121-7.
11. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
12. Corona T, Rodríguez J, Otero E, Stopp L. MS in Mexico. Update 1996; 10: 23-4.
13. Aronson KJ, Goldberg E, Cleghorn G. Sociodemographic characteristics and health status of persons whith MS and their caregivers. MS Management 1996; 3: 1-15.
14. Pryse-Phillips W, Costello F. The epidemiology of multiple sclerosis. In Cook S, ed. Handbook of multiple sclerosis. 3 ed. New York: Marcel Dekker; 2001. p. 5-31.
15. Kurtzke JK, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228-35.
16. Skegg DC, Corwin PA, Craven RS, Malloch JA, Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987; 50: 134-9.
17. Gronning M, Mellgren SI. Multiple sclerosis in the two northernmost countries of Northway. Acta Neurol Scand 1985; 72: 321-7.
18. Palffy G, Czopf J, Gyodi E. Multiple sclerosis in Baranya Country in Hungarians and in Gypsies. In Firnhaber W, Lauer K, eds. Multiple sclerosis in Europe: an epidemiological update. Darmstadt: Leutchturm Verlag; 1993. p. 274-8.
19. Weinshenker BG. The natural history of multiple sclerosis. In Antel JP, ed. Neurologic clinics. Philadelphia: WB Saunders; 1995. p. 119-47.
20. Karni A, Abramsky O. Association of MS with thyroid disorders. Neurology 1999; 534: 883-5.
21. Pryse-Phillips W, Costello F. The epidemiology of multiple sclerosis. In Cook S, ed. Handbook of multiple sclerosis. 3 ed. New York: Marcel Dekker; 2001. p. 15-31.
22. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroinmunol 1994; 541: 1-17.
23. Phillips JT. Regression analysis of multiple sclerosis population data predicts multigenic interaction and minor combined effects of HLA and T-cell receptor genes. Neurology 1993; 43 (Suppl): 205.
24. Haegert DG, Swiftt FV, Benedikz J. Evidence for a complex role of HLA class II genotypes and susceptibility to multiple sclerosis in Iceland. Neurology 1996; 46: 1107-11.
25. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988; 38: 990-1.
26. Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994; 36 (Suppl): 180-93.
27. Pnitch HS. Interferons in multiple sclerosis. Drug 1992; 44: 946-62.
28. Rodríguez M, Silva A, Cross S. Optic neuritis: a population based study in Olsmted Country, Minnesota. Neurology 1994; 44: 374.
29. Minderhoud JM, Van der Hoeven JH, Prange AJA. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Nuerol Scand 1988; 78: 15-8.
30. Runmarker B, Andersen O. Prognostic factors in multiple sclerosis incidence cohort with 25 years of follow-up. Brain 1993; 116: 117-34.
31. Convavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
32. Weinshenker BG, Rice GPA, Noseworthy JH, Cariere W, Baskeville J, Ebers GC. The natural history of multiple sclerosis: a geographical based study-III. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-56.
33. Hoodge JP, Redekop WP. Multiple sclerosis with very late onset. Neurology 1992; 42: 1907-10.
34. Poser CM. Multiple sclerosis: diagnosis and treatment. Med Princ Pract 1992; 93: 1-6.
35. McAlpine D. Symptoms and signs. In McAlpine D, Lumdsen CE, Acheson E, eds. Multiple sclerosis: a reappraisal. Baltimore: Williams & Wilkins; 1972. p. 132-96.
36. Muller R. Studies on disseminated sclerosis with special reference to symptomatology, course and prognosis. Acta Med Scand Suppl 1949; 222: 1-214.
37. Adams DK, Sutherland JM. Early clinical manifestations of disseminated sclerosis. Br Med J 1950; 2: 431-6.
38. Kurtzke JF. Clinical manifestations of multiple sclerosis. In Vinken PJ, Bruyn GW. Handbook of clinical neurology. Vol. 9. Multiple sclerosis and other demyelinating deseases. Amsterdam: North Holland; 1970. p. 161-216.
39. Odie JP. CEDECOOP: multiple sclerosis with very late onset. Neurology 1992; 42: 1907-10.
40. Pazzaglia P, Azzimondi G. Multiple sclerosis with very late onset. Report of six cases and review of the literature. EW Neurol 1994; 34: 332-6.
41. Hammond S. The epidemiology of multiple sclerosis in the Australian cities: Perth, Umcorthe and Hobort. Brain 1989; 111: 1-25.
42. Noseworthy J, Paty D, Wonnocolt T, Feasby T, Ebers G. Multiple Sclerosis after age fifty. Neurology 1983; 33: 1537-44.
43. Friedman AP, Davison C. Multiple sclerosis with late onset of symptoms. Arch Neurol Psychiatry 1954; 54: 348-60.
44. Cottrell SS, Wilson SAK. The affective symptomatology of disseminated sclerosis. J Neurol Psychopatol 1926; 7: 1-30.
45. Whitlock FA, Siskind MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1880; 43: 861-5.
46. Baretz RM, Stephenson GR. Emotional responses to multiple sclerosis. Psychosomatics 1981; 22: 117-27.
47. Kurtzke JF. Clinical definition for multiple sclerosis treatment trials. Ann Neurol 1994; 36 (Suppl): 73-9.
48. Perkin GD, Rose FC. Optic neuritis and its differential diagnosis. Oxford: Oxford University Press; 1979.
49. Slamovits TL, Rosen CE, Cheng KP, Striph GG. Visual recovery in patients with optic neuritis and visual loss to no light perception. Am J Ophthalmol 1991; 111: 209-21.
50. Steinmetz R, Kearns TP. H-R-R pseudoisochromatic plates as a diagnostic aid in retrobulbar neuritis of multiple sclerosis. Am J Ophthalmol 1956; 41: 833-7.
51. Stanley JA, Baise G. The swinging flashlight test to detect minimal optic neuropathy. Arch Ophthalmol 1968; 80: 769-71.
52. Miller DH. The role of MRI in the diagnosis and treatment of multiple sclerosis. MS Management 1995; 2: 36-42.